Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and Selection – A Narrative Review

The new Calcitonin Gene-Related Peptide (CGRP)-targeted therapies have proven high efficacy and tolerability in episodic and chronic migraine. Eptinezumab is a humanized monoclonal antibody that selectively binds CGRP with high affinity. Eptinezumab was approved by the Food and Drug Administration o...

Descripción completa

Detalles Bibliográficos
Autores principales: Altamura, Claudia, Brunelli, Nicoletta, Marcosano, Marilena, Alesina, Alessandro, Fofi, Luisa, Vernieri, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680459/
https://www.ncbi.nlm.nih.gov/pubmed/38023625
http://dx.doi.org/10.2147/TCRM.S263824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680459/
https://www.ncbi.nlm.nih.gov/pubmed/38023625
http://dx.doi.org/10.2147/TCRM.S263824

Ejemplares similares